Metabolomics and lipidomics study on serum metabolite signatures in Alzheimer's disease and mild cognitive impairment

Abstract

Background: Alzheimer's disease (AD) and mild cognitive impairment (MCI) are leading causes of dementia in the elderly worldwide, characterized by abnormal cognition and behavior, which complicates diagnosis and treatment. Metabolites play a critical role in cellular process related to the pathogenesis of AD and MCI.

The paper